
Science Applications International reported Q1 adjusted earnings per share of $3.23, beating the $2.28 estimate, and revenue of $1.91 billion exceeded the $1.82 billion forecast with 0.5% organic growth. It raised fiscal 2027 EPS guidance to $9.90–$10.10, upped EBITDA outlook to $720M–$730M, and lifted margin forecast to 10.1%–10.3%.
Science Applications International reported adjusted EPS of $3.23 for Q1 fiscal 2027, well above the $2.28 consensus, and revenue of $1.91 billion, topping the $1.82 billion forecast and up from $1.88 billion a year ago.
Excluding the SilverEdge acquisition, the company achieved 0.5% organic revenue growth, driven by improved contract profitability and healthy cash generation across its defense technology and services segments.
The company increased its fiscal 2027 adjusted EPS guidance to $9.90–$10.10 (midpoint $10.00) from $9.50–$9.70, and raised adjusted EBITDA outlook to $720M–$730M with margin expectations lifted to 10.1%–10.3%.
Adjusted EBITDA margin expanded to 11.6% in the quarter, up from 8.4%, reflecting disciplined execution that underpinned the stronger results, and management highlighted continued focus on capital returns and profitability targets.